Alterola Biotech, Inc. (ABTI) Stock Price & Analysis
Alterola Biotech, Inc. (ABTI) closed at USD 0 on Thursday, October 22, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 22, 2026 session ranged USD 0.2–0.2 on volume of 20 shares. Market capitalization is $291,900, with a 52-week range of USD 0–0.2 (PNK). Source: Nexqual, retrieved October 24, 2026 at 01:52 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ABTI.md
Key facts (ABTI)
- Analysts: None.
- Total return with dividends: 1Y +0.0% vs S&P 500 +13.4%; 5Y -99.9% vs S&P 500 +76.9%.
Analysts (ABTI)
Consensus None.
Total return (dividends reinvested) (ABTI)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +0.0% | -99.9% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +0.0% | -77.2% |
| Volatility (annualized) | 479.9% | 301.7% |
| Max drawdown | -96.9% (Dec 2025→Jul 2026) | -99.9% (Nov 2021→Jun 2025) |
ABTI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 01:52 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.2 |
| Day Range | USD 0.2 – 0.2 |
| 52-Week Range | USD 0 – 0.2 |
| Volume | 20 shares |
| Market Cap | $291,900 |
| Exchange | PNK |
Technical Analysis (ABTI)
Nexqual's technical model rates ABTI "STRONG SELL" based on 0 bullish and 5 bearish signals across 126 daily candles, as of October 24, 2026 at 01:52 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ABTI)
Wall Street analysts rate ABTI "None", per Nexqual as of October 24, 2026 at 01:52 UTC.
| Consensus Rating | None |
|---|
Earnings (ABTI)
Source: Nexqual, October 24, 2026 at 01:52 UTC.
Financials & Fundamentals (ABTI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.32 |
| Total Cash | $82,720 |
| Total Debt | $2.35M |
Source: Nexqual, October 24, 2026 at 01:52 UTC.
Financial Health Score (ABTI)
Nexqual rates Alterola Biotech, Inc.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 01:52 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% (last 12 months) |
| Balance Sheet | Mixed — $83K cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$2M (TTM) |
| Efficiency | Mixed — No data |
Ownership (ABTI)
| Insider Ownership | +90.41% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.46B |
| Float | 377.24M |
Source: Nexqual, October 24, 2026 at 01:52 UTC.
Leadership (ABTI)
Alterola Biotech, Inc. is led by David John Hitchcock O.B.E., Chief Executive Officer, per Nexqual as of October 24, 2026 at 01:52 UTC.
| Chief Executive Officer | David John Hitchcock O.B.E. |
|---|---|
| CFO & Secretary | Nathan Thompson |
| COO & Director | Colin G. Stott B.Sc. |
| IP Counsel, Chief IP Officer & Director | Dominic Schiller |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | USD 40.7 | ▼ 3.26% |
| BHC | Bausch Health Companies Inc. | USD 6.44 | ▼ 0.77% |
| HCM | HUTCHMED (China) Limited | USD 14.36 | ▲ 0.56% |
| AMLX | Amylyx Pharmaceuticals, Inc. | USD 27.2 | ▼ 4.8% |
| RGC | Regencell Bioscience Holdings L | USD 7.67 | ▼ 21.81% |
| LQDA | Liquidia Corporation | USD 42.65 | ▲ 7.46% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 01:52 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt